Tavanta Therapeutics Announces New Preclinical Data for its Cystic Fibrosis Candidate TAVT-135 at Two Prominent Scientific Conferences
~ Data support potential for TAVT-135 to address significant unmet needs in people with cystic fibrosis, including those who are ineligible for, o...
United States Lynne Powell Andreas Maetzel Lindsay Rocco International Conference Poster Presentation Cystic Fibrosis Foundation
Source: businessinsider.com